BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  Johnson & Johnson to Pay $2.2 Billion to End Risperdal Sales Probe

  June 11, 2012

   · 

  1 min read
• Business

  Protalix Biotherapeutics, Inc. Gets $25 Million Payment From Pfizer Inc.

  June 11, 2012

   · 

  4 min read
• Deals

  EQT to Buy BSN Medical GmbH for $2.26 Billion

  June 11, 2012

   · 

  1 min read
• FDA

  Nexstim Announces FDA Clearance for NexSpeech® – Enabling Noninvasive Speech Mapping Prior to Neurosurgery

  June 11, 2012

   · 

  2 min read
• FDA

  Mevion Medical Systems Announces FDA 510(k) Clearance for the MEVION S250 Proton Therapy System

  June 11, 2012

   · 

  2 min read
• Pharm Country

  Merck Serono Staff Mull Further Strike Action

  June 11, 2012

   · 

  1 min read
• Drug Development

  GlaxoSmithKline Reports Data From Phase III Study of Once-weekly Albiglutide in Type 2 Diabetes

  June 11, 2012

   · 

  3 min read
• Policy

  Judges Skeptical of $60 Million NeuroVision Win Over NuVasive, Inc.

  June 11, 2012

   · 

  1 min read
• BioMidwest

  Synergetics USA, Inc. to Participate in Sidoti & Company, LLC’s Micro Cap Conference

  June 11, 2012

   · 

  2 min read
• Drug Development

  ZIOPHARM Oncology, Inc. Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer

  June 11, 2012

   · 

  1 min read